Table I.
Combination Index values calculated for the combination treatment of chronic lymphocytic leukaemia (CLL) cells
CLL patient | LBH589 | SAHA | ||||
---|---|---|---|---|---|---|
1 nM | 2.5 nM | 5 nM | 0.5 μM | 1 μM | 2 μM | |
1 | 0.38 | 0.26 | 0.61 | N/D | 0.62 | 0.74 |
2 | 1.09 | 0.66 | 0.74 | 0.98 | 0.61 | 0.72 |
3 | 0.29 | 0.19 | 0.27 | 0.12 | 0.18 | 0.28 |
4 | 0.44 | 0.51 | 0.38 | N/D | N/D | N/D |
5 | N/D | N/D | N/D | 0.39 | 0.10 | 0.19 |
CLL, chronic lymphocytic leukaemia; LBH589, panobinostat; SAHA, suberoylanilide hydroxamic acid.